resveratrol has been researched along with scopolamine hydrobromide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Gacar, N; Gocmez, SS; Komsuoglu Celikyurt, I; Mutlu, O; Ulak, G; Utkan, T | 1 |
| Bhattacharya, SK; Gupta, LK; Gupta, R; Mediratta, PK | 1 |
| Allam, A; Bariya, A; Butani, SB; Othman, S; Rajput, A | 1 |
| da Silva, AD; de Assis, PM; Dutra, RC; Fávero, A; Goliatt, PVZC; Marion, GM; Meinel, RS; Menegasso, JF; Nunes, VSP; Raposo, NRB | 1 |
| Chen, N; He, C; He, X; Li, Y; Liu, Q; Liu, S; Xiao, P; Yi, F | 1 |
| Kaur, A; Kumar, S; Maurya, VK; Mishra, S; Saxena, SK | 1 |
1 review(s) available for resveratrol and scopolamine hydrobromide
| Article | Year |
|---|---|
Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antioxidants; Berberine; Curcumin; Graves Ophthalmopathy; Humans; Mydriatics; Proto-Oncogene Mas; Quercetin; Resveratrol; Scopolamine; Withanolides | 2020 |
6 other study(ies) available for resveratrol and scopolamine hydrobromide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats.
Topics: Animals; Avoidance Learning; Male; Maze Learning; Mecamylamine; Memory Disorders; Rats; Rats, Wistar; Reaction Time; Resveratrol; Scopolamine; Stilbenes | 2011 |
Effect of resveratrol on scopolamine-induced cognitive impairment in mice.
Topics: Animals; Avoidance Learning; Behavior, Animal; Cognition Disorders; Injections, Intraperitoneal; Maze Learning; Memory Disorders; Mice; Motor Activity; Muscarinic Antagonists; Neuroprotective Agents; Reaction Time; Resveratrol; Scopolamine; Stilbenes; Treatment Outcome | 2012 |
In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization.
Topics: Administration, Intranasal; Administration, Oral; Alzheimer Disease; Amnesia; Animals; Disease Models, Animal; Drug Carriers; Emulsions; Hydrogels; In Vitro Techniques; Male; Nanostructures; Particle Size; Polysaccharides, Bacterial; Rats; Resveratrol; Scopolamine | 2018 |
In silico, in vitro and in vivo studies indicate resveratrol analogue as a potential alternative for neuroinflammatory disorders.
Topics: Animals; Anti-Inflammatory Agents; Computer Simulation; In Vitro Techniques; Inflammation; Lipopolysaccharides; Male; Mice; Molecular Docking Simulation; Nervous System Diseases; Neuroprotective Agents; Resveratrol; Scopolamine | 2020 |
Resveratrol oligomers from Paeonia suffruticosa protect mice against cognitive dysfunction by regulating cholinergic, antioxidant and anti-inflammatory pathways.
Topics: Acetylcholinesterase; Animals; Anti-Inflammatory Agents; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Cognitive Dysfunction; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Paeonia; PC12 Cells; Plant Extracts; Rats; Resveratrol; Scopolamine | 2020 |